A Study of Oral Venetoclax Tablet in Combination With Subcutaneous Low-Dose Cytarabine (LDAC) Injection to Assess Adverse Events in Adult Japanese Participants With Acute Myeloid Leukemia (AML)

Tohoku University Hospital /ID# 223169, Sendai

NHO Nagoya Medical Center /ID# 223671, Nagoya

Aichi Cancer Center Hospital /ID# 223134, Nagoya

University of Fukui Hospital /ID# 223133, Yoshida-gun

Kyushu University Hospital /ID# 223136, Fukuoka

Gunmaken Saiseikai Maebashi Hospital /ID# 223301, Maebashi

National Hospital Organization Mito Medical Center /ID# 223392, Higashi Ibaraki-gun

Hitachi General Hospital /ID# 223084, Hitachi-shi

University Hospital Kyoto Prefectural University of Medicine /ID# 223135, Kyoto

Okayama University Hospital /ID# 222990, Okayama

Osaka City University Hospital /ID# 224269, Osaka

Saitama Medical University International Medical Center /ID# 223575, Hidaka-shi

Juntendo University Hospital /ID# 223086, Bunkyo-ku

The Jikei University Daisan Hospital /ID# 223418, Komae-shi

NTT Medical Center Tokyo /ID# 223574, Shinagawa-ku

Yamagata University Hospital /ID# 223032, Yamagata